1887

Abstract

infections can cause pneumocystis pneumonia (PCP) or lead to colonization without signs of PCP. Over the years, different genotypes of have been discovered. Genomic typing of in different subpopulations can contribute to unravelling the pathogenesis, transmission and spread of the different genotypes. In this study, we wanted to determine the distribution of genotypes in immunocompetent and immunocompromised patients in The Netherlands and determine the clinical relevance of these detected mutations. A real-time PCR targeting the major surface glycoprotein gene (MSG) was used as a screening test for the presence of DNA. Samples positive for MSG were genotyped based on the internal transcribed spacer (ITS) and dihydropteroate synthase (DHPS) genes. Of the 595 included bronchoalveolar lavage fluid samples, 116 revealed the presence of DNA. A total of 52 of the 116 samples were ITS genotyped and 58 DHPS genotyped. The ITS genotyping revealed 17 ITS types, including two types that have not been described previously. There was no correlation between ITS genotype and underlying disease. All ITS- and DHPS-genotyped samples were found in immunocompromised patients. Of the 58 DHPS-genotyped samples, 50 were found to be WT. The other eight samples revealed a mixed genotype consisting of WT and type 1. The majority of the latter recovered on trimethoprim–sulfamethoxazole suggesting no clinical relevance for this mutation.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.076257-0
2014-10-01
2019-11-14
Loading full text...

Full text loading...

/deliver/fulltext/jmm/63/10/1294.html?itemId=/content/journal/jmm/10.1099/jmm.0.076257-0&mimeType=html&fmt=ahah

References

  1. Alanio A., Desoubeaux G., Sarfati C., Hamane S., Bergeron A., Azoulay E., Molina J. M., Derouin F., Menotti J.. ( 2011;). Real-time PCR assay-based strategy for differentiation between active Pneumocystis jirovecii pneumonia and colonization in immunocompromised patients. . Clin Microbiol Infect 17:, 1531–1537. [CrossRef][PubMed]
    [Google Scholar]
  2. Alvarez-Martínez M. J., Moreno A., Miró J. M., Valls M. E., Rivas P. V., de Lazzari E., Sued O., Benito N., Domingo P.. & other authors ( 2008;). Pneumocystis jirovecii pneumonia in Spanish HIV-infected patients in the combined antiretroviral therapy era: prevalence of dihydropteroate synthase mutations and prognostic factors of mortality. . Diagn Microbiol Infect Dis 62:, 34–43. [CrossRef][PubMed]
    [Google Scholar]
  3. Armstrong W., Meshnick S., Kazanjian P.. ( 2000;). Pneumocystis carinii mutations associated with sulfa and sulfone prophylaxis failures in immunocompromised patients. . Microbes Infect 2:, 61–67. [CrossRef][PubMed]
    [Google Scholar]
  4. Banerji S., Lugli E. B., Miller R. F., Wakefield A. E.. ( 1995;). Analysis of genetic diversity at the arom locus in isolates of Pneumocystis carinii. . J Eukaryot Microbiol 42:, 675–679. [CrossRef][PubMed]
    [Google Scholar]
  5. Barbounis V., Aperis G., Gambletsas E., Koumakis G., Demiris M., Vassilomanolakis M., Efremidis A.. ( 2005;). Pneumocystis carinii pneumonia in patients with solid tumors and lymphomas: predisposing factors and outcome. . Anticancer Res 25:, 651–655.[PubMed]
    [Google Scholar]
  6. Beard C. B., Carter J. L., Keely S. P., Huang L., Pieniazek N. J., Moura I. N., Roberts J. M., Hightower A. W., Bens M. S.. & other authors ( 2000;). Genetic variation in Pneumocystis carinii isolates from different geographic regions: implications for transmission. . Emerg Infect Dis 6:, 265–272. [CrossRef][PubMed]
    [Google Scholar]
  7. Beard C. B., Roux P., Nevez G., Hauser P. M., Kovacs J. A., Unnasch T. R., Lundgren B.. ( 2004;). Strain typing methods and molecular epidemiology of Pneumocystis pneumonia. . Emerg Infect Dis 10:, 1729–1735. [CrossRef][PubMed]
    [Google Scholar]
  8. Beser J., Hagblom P., Fernandez V.. ( 2007;). Frequent in vitro recombination in internal transcribed spacers 1 and 2 during genotyping of Pneumocystis jirovecii. . J Clin Microbiol 45:, 881–886. [CrossRef][PubMed]
    [Google Scholar]
  9. Botterel F., Cabaret O., Foulet F., Cordonnier C., Costa J. M., Bretagne S.. ( 2012;). Clinical significance of quantifying Pneumocystis jirovecii DNA by using real-time PCR in bronchoalveolar lavage fluid from immunocompromised patients. . J Clin Microbiol 50:, 227–231. [CrossRef][PubMed]
    [Google Scholar]
  10. de Boer M. G., Bruijnesteijn van Coppenraet L. E., Gaasbeek A., Berger S. P., Gelinck L. B., van Houwelingen H. C., van den Broek P., Kuijper E. J., Kroon F. P., Vandenbroucke J. P.. ( 2007;). An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source?. Clin Infect Dis 44:, 1143–1149. [CrossRef][PubMed]
    [Google Scholar]
  11. de Boer M. G., de Fijter J. W., Kroon F. P.. ( 2011;). Outbreaks and clustering of Pneumocystis pneumonia in kidney transplant recipients: a systematic review. . Med Mycol 49:, 673–680.[PubMed]
    [Google Scholar]
  12. De Brauwer E. I., Jacobs J. A., Nieman F., Bruggeman C. A., Wagenaar S. S., Drent M.. ( 2000;). Cytocentrifugation conditions affecting the differential cell count in bronchoalveolar lavage fluid. . Anal Quant Cytol Histol 22:, 416–422.[PubMed]
    [Google Scholar]
  13. Dei-Cas E., Brun-Pascaud M., Bille-Hansen V., Allaert A., Aliouat E. M.. ( 1998;). Animal models of pneumocystosis. . FEMS Immunol Med Microbiol 22:, 163–168. [CrossRef][PubMed]
    [Google Scholar]
  14. Denis C. M., Mazars E., Guyot K., Odberg-Ferragut C., Viscogliosi E., Dei-Cas E., Wakefield A. E.. ( 2000;). Genetic divergence at the SODA locus of six different formae speciales of Pneumocystis carinii. . Med Mycol 38:, 289–300. [CrossRef][PubMed]
    [Google Scholar]
  15. Edman J. C., Kovacs J. A., Masur H., Santi D. V., Elwood H. J., Sogin M. L.. ( 1988;). Ribosomal RNA sequence shows Pneumocystis carinii to be a member of the fungi. . Nature 334:, 519–522. [CrossRef][PubMed]
    [Google Scholar]
  16. Edman J. C., Hatton T. W., Nam M., Turner R., Mei Q., Angus C. W., Kovacs J. A.. ( 1996;). A single expression site with a conserved leader sequence regulates variation of expression of the Pneumocystis carinii family of major surface glycoprotein genes. . DNA Cell Biol 15:, 989–999. [CrossRef][PubMed]
    [Google Scholar]
  17. Esteves F., Montes-Cano M. A., de la Horra C., Costa M. C., Calderón E. J., Antunes F., Matos O.. ( 2008;). Pneumocystis jirovecii multilocus genotyping profiles in patients from Portugal and Spain. . Clin Microbiol Infect 14:, 356–362. [CrossRef][PubMed]
    [Google Scholar]
  18. Flori P., Bellete B., Durand F., Raberin H., Cazorla C., Hafid J., Lucht F., Sung R. T.. ( 2004;). Comparison between real-time PCR, conventional PCR and different staining techniques for diagnosing Pneumocystis jiroveci pneumonia from bronchoalveolar lavage specimens. . J Med Microbiol 53:, 603–607. [CrossRef][PubMed]
    [Google Scholar]
  19. Gupta R., Mirdha B. R., Guleria R., Agarwal S. K., Samantaray J. C., Kumar L., Kabra S. K., Luthra K., Sreenivas V.. ( 2010;). Genotyping and phylogenetic analysis of Pneumocystis jirovecii isolates from India. . Infect Genet Evol 10:, 712–719. [CrossRef][PubMed]
    [Google Scholar]
  20. Hauser P. M., Blanc D. S., Sudre P., Senggen Manoloff E., Nahimana A., Bille J., Weber R., Francioli P.. ( 2001;). Genetic diversity of Pneumocystis carinii in HIV-positive and -negative patients as revealed by PCR-SSCP typing. . AIDS 15:, 461–466. [CrossRef][PubMed]
    [Google Scholar]
  21. Helweg-Larsen J., Tsolaki A. G., Miller R. F., Lundgren B., Wakefield A. E.. ( 1998;). Clusters of Pneumocystis carinii pneumonia: analysis of person-to-person transmission by genotyping. . QJM 91:, 813–820. [CrossRef][PubMed]
    [Google Scholar]
  22. Helweg-Larsen J., Benfield T. L., Eugen-Olsen J., Lundgren J. D., Lundgren B.. ( 1999;). Effects of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of AIDS-associated P. carinii pneumonia. . Lancet 354:, 1347–1351. [CrossRef][PubMed]
    [Google Scholar]
  23. Helweg-Larsen J., Lee C. H., Jin S., Hsueh J. Y., Benfield T. L., Hansen J., Lundgren J. D., Lundgren B.. ( 2001;). Clinical correlation of variations in the internal transcribed spacer regions of rRNA genes in Pneumocystis carinii f.sp. hominis. . AIDS 15:, 451–459. [CrossRef][PubMed]
    [Google Scholar]
  24. Höcker B., Wendt C., Nahimana A., Tönshoff B., Hauser P. M.. ( 2005;). Molecular evidence of Pneumocystis transmission in pediatric transplant unit. . Emerg Infect Dis 11:, 330–332. [CrossRef][PubMed]
    [Google Scholar]
  25. Hosoya N., Takahashi T., Wada M., Endo T., Nakamura T., Sakashita H., Kimura K., Ohnishi K., Nakamura Y.. & other authors ( 2000;). Genotyping of Pneumocystis carinii f. sp. hominis isolates in Japan based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. . Microbiol Immunol 44:, 591–596. [CrossRef][PubMed]
    [Google Scholar]
  26. Huang L., Beard C. B., Creasman J., Levy D., Duchin J. S., Lee S., Pieniazek N., Carter J. L., del Rio C.. & other authors ( 2000;). Sulfa or sulfone prophylaxis and geographic region predict mutations in the Pneumocystis carinii dihydropteroate synthase gene. . J Infect Dis 182:, 1192–1198. [CrossRef][PubMed]
    [Google Scholar]
  27. Hui M., Kwok W. T.. ( 2006;). Pneumocystis carinii pneumonia in Hong Kong: a 10 year retrospective study. . J Med Microbiol 55:, 85–88. [CrossRef][PubMed]
    [Google Scholar]
  28. Jarboui M. A., Sellami A., Sellami H., Cheikhrouhou F., Makni F., Ayadi A.. ( 2011;). Dihydropteroate synthase gene mutations in Pneumocystis jiroveci strains isolated from immunocompromised patients. . Pathol Biol (Paris) 59:, 222–225. [CrossRef][PubMed]
    [Google Scholar]
  29. Kling H. M., Shipley T. W., Patil S., Morris A., Norris K. A.. ( 2009;). Pneumocystis colonization in immunocompetent and simian immunodeficiency virus-infected cynomolgus macaques. . J Infect Dis 199:, 89–96. [CrossRef][PubMed]
    [Google Scholar]
  30. Kling H. M., Shipley T. W., Patil S. P., Kristoff J., Bryan M., Montelaro R. C., Morris A., Norris K. A.. ( 2010;). Relationship of Pneumocystis jiroveci humoral immunity to prevention of colonization and chronic obstructive pulmonary disease in a primate model of HIV infection. . Infect Immun 78:, 4320–4330. [CrossRef][PubMed]
    [Google Scholar]
  31. Kutty G., Ma L., Kovacs J. A.. ( 2001;). Characterization of the expression site of the major surface glycoprotein of human-derived Pneumocystis carinii. . Mol Microbiol 42:, 183–193. [CrossRef][PubMed]
    [Google Scholar]
  32. Lane B. R., Ast J. C., Hossler P. A., Mindell D. P., Bartlett M. S., Smith J. W., Meshnick S. R.. ( 1997;). Dihydropteroate synthase polymorphisms in Pneumocystis carinii. . J Infect Dis 175:, 482–485. [CrossRef][PubMed]
    [Google Scholar]
  33. Larsen H. H., Masur H., Kovacs J. A., Gill V. J., Silcott V. A., Kogulan P., Maenza J., Smith M., Lucey D. R., Fischer S. H.. ( 2002;). Development and evaluation of a quantitative, touch-down, real-time PCR assay for diagnosing Pneumocystis carinii pneumonia. . J Clin Microbiol 40:, 490–494. [CrossRef][PubMed]
    [Google Scholar]
  34. Le Gal S., Rouille A., Gueguen P., Virmaux M., Berthou C., Guillerm G., Couturaud F., Le Meur Y., Damiani C.. & other authors ( 2013;). Pneumocystis jirovecii haplotypes at the internal transcribed spacers of the rRNA operon in French HIV-negative patients with diverse clinical presentations of Pneumocystis infections. . Med Mycol 51:, 851–862. [CrossRef][PubMed]
    [Google Scholar]
  35. Lee C. H., Helweg-Larsen J., Tang X., Jin S., Li B., Bartlett M. S., Lu J. J., Lundgren B., Lundgren J. D.. & other authors ( 1998;). Update on Pneumocystis carinii f. sp. hominis typing based on nucleotide sequence variations in internal transcribed spacer regions of rRNA genes. . J Clin Microbiol 36:, 734–741.[PubMed]
    [Google Scholar]
  36. Linssen C. F., Jacobs J. A., Beckers P., Templeton K. E., Bakkers J., Kuijper E. J., Melchers W. J., Drent M., Vink C.. ( 2006;). Inter-laboratory comparison of three different real-time PCR assays for the detection of Pneumocystis jiroveci in bronchoalveolar lavage fluid samples. . J Med Microbiol 55:, 1229–1235. [CrossRef][PubMed]
    [Google Scholar]
  37. Linssen C. F. M., Jacobs J. A., Schouten J. S. A. G., van Mook W. N. K. A., Ramsay G., Drent M.. ( 2008;). Influence of antibiotic therapy on the cytological diagnosis of ventilator-associated pneumonia. . Intensive Care Med 34:, 865–872. [CrossRef][PubMed]
    [Google Scholar]
  38. Lu J. J., Bartlett M. S., Shaw M. M., Queener S. F., Smith J. W., Ortiz-Rivera M., Leibowitz M. J., Lee C. H.. ( 1994;). Typing of Pneumocystis carinii strains that infect humans based on nucleotide sequence variations of internal transcribed spacers of rRNA genes. . J Clin Microbiol 32:, 2904–2912.[PubMed]
    [Google Scholar]
  39. Ma L., Kovacs J. A., Cargnel A., Valerio A., Fantoni G., Atzori C.. ( 2002a;). Mutations in the dihydropteroate synthase gene of human-derived Pneumocystis carinii isolates from Italy are infrequent but correlate with prior sulfa prophylaxis. . J Infect Dis 185:, 1530–1532. [CrossRef][PubMed]
    [Google Scholar]
  40. Ma L., Kutty G., Jia Q., Imamichi H., Huang L., Atzori C., Beckers P., Groner G., Beard C. B., Kovacs J. A.. ( 2002b;). Analysis of variation in tandem repeats in the intron of the major surface glycoprotein expression site of the human form of Pneumocystis carinii. . J Infect Dis 186:, 1647–1654. [CrossRef][PubMed]
    [Google Scholar]
  41. Matsumura Y., Shindo Y., Iinuma Y., Yamamoto M., Shirano M., Matsushima A., Nagao M., Ito Y., Takakura S.. & other authors ( 2011;). Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes. . BMC Infect Dis 11:, 76. [CrossRef][PubMed]
    [Google Scholar]
  42. Miller R. F., Wakefield A. E.. ( 1999;). Pneumocystis carinii genotypes and severity of pneumonia. . Lancet 353:, 2039–2040. [CrossRef][PubMed]
    [Google Scholar]
  43. Montes-Cano M. A., de la Horra C., Martin-Juan J., Varela J. M., Torronteras R., Respaldiza N., Medrano F. J., Calderón E. J.. ( 2004;). Pneumocystis jiroveci genotypes in the Spanish population. . Clin Infect Dis 39:, 123–128. [CrossRef][PubMed]
    [Google Scholar]
  44. Mori S., Cho I., Sugimoto M.. ( 2009;). A followup study of asymptomatic carriers of Pneumocystis jiroveci during immunosuppressive therapy for rheumatoid arthritis. . J Rheumatol 36:, 1600–1605. [CrossRef][PubMed]
    [Google Scholar]
  45. Morris A., Wei K., Afshar K., Huang L.. ( 2008;). Epidemiology and clinical significance of Pneumocystis colonization. . J Infect Dis 197:, 10–17. [CrossRef][PubMed]
    [Google Scholar]
  46. Nahimana A., Blanc D. S., Francioli P., Bille J., Hauser P. M.. ( 2000;). Typing of Pneumocystis carinii f. sp. hominis by PCR-SSCP to indicate a high frequency of co-infections. . J Med Microbiol 49:, 753–758.[PubMed]
    [Google Scholar]
  47. Nahimana A., Rabodonirina M., Zanetti G., Meneau I., Francioli P., Bille J., Hauser P. M.. ( 2003;). Association between a specific Pneumocystis jiroveci dihydropteroate synthase mutation and failure of pyrimethamine/sulfadoxine prophylaxis in human immunodeficiency virus-positive and -negative patients. . J Infect Dis 188:, 1017–1023. [CrossRef][PubMed]
    [Google Scholar]
  48. Navin T. R., Beard C. B., Huang L., del Rio C., Lee S., Pieniazek N. J., Carter J. L., Le T., Hightower A., Rimland D.. ( 2001;). Effect of mutations in Pneumocystis carinii dihydropteroate synthase gene on outcome of P. carinii pneumonia in patients with HIV-1: a prospective study. . Lancet 358:, 545–549. [CrossRef][PubMed]
    [Google Scholar]
  49. Nevez G., Totet A., Jounieaux V., Schmit J. L., Dei-Cas E., Raccurt C.. ( 2003;). Pneumocystis jiroveci internal transcribed spacer types in patients colonized by the fungus and in patients with pneumocystosis from the same French geographic region. . J Clin Microbiol 41:, 181–186. [CrossRef][PubMed]
    [Google Scholar]
  50. Nevez G., Chabé M., Rabodonirina M., Virmaux M., Dei-Cas E., Hauser P. M., Totet A.. ( 2008;). Nosocomial Pneumocystis jirovecii infections. . Parasite 15:, 359–365. [CrossRef][PubMed]
    [Google Scholar]
  51. Nimri L. F., Moura I. N., Huang L., del Rio C., Rimland D., Duchin J. S., Dotson E. M., Beard C. B.. ( 2002;). Genetic diversity of Pneumocystis carinii f. sp. hominis based on variations in nucleotide sequences of internal transcribed spacers of rRNA genes. . J Clin Microbiol 40:, 1146–1151. [CrossRef][PubMed]
    [Google Scholar]
  52. Phair J., Muñoz A., Detels R., Kaslow R., Rinaldo C., Saah A..Multicenter AIDS Cohort Study Group ( 1990;). The risk of Pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. . N Engl J Med 322:, 161–165. [CrossRef][PubMed]
    [Google Scholar]
  53. Rabodonirina M., Vanhems P., Couray-Targe S., Gillibert R. P., Ganne C., Nizard N., Colin C., Fabry J., Touraine J. L.. & other authors ( 2004;). Molecular evidence of interhuman transmission of Pneumocystis pneumonia among renal transplant recipients hospitalized with HIV-infected patients. . Emerg Infect Dis 10:, 1766–1773. [CrossRef][PubMed]
    [Google Scholar]
  54. Rabodonirina M., Vaillant L., Taffé P., Nahimana A., Gillibert R. P., Vanhems P., Hauser P. M.. ( 2013;). Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia. . Emerg Infect Dis 19:, 21–28, quiz 186. [CrossRef][PubMed]
    [Google Scholar]
  55. Resnick I. B., Averbuch D., Aker M., Engelhard D.. ( 2005;). Is Pneumocystis carinii pneumonia after stem cell transplantations a contagious disease?. Clin Transplant 19:, 427–431. [CrossRef][PubMed]
    [Google Scholar]
  56. Ritter M. L., Pirofski L.. ( 2009;). Mycophenolate mofetil: effects on cellular immune subsets, infectious complications, and antimicrobial activity. . Transpl Infect Dis 11:, 290–297. [CrossRef][PubMed]
    [Google Scholar]
  57. Sassi M., Ripamonti C., Mueller N. J., Yazaki H., Kutty G., Ma L., Huber C., Gogineni E., Oka S.. & other authors ( 2012;). Outbreaks of Pneumocystis pneumonia in 2 renal transplant centers linked to a single strain of Pneumocystis: implications for transmission and virulence. . Clin Infect Dis 54:, 1437–1444. [CrossRef][PubMed]
    [Google Scholar]
  58. Sheikholeslami M. F., Sadraei J., Farnia P., Forozandeh Moghadam M., Emadi Kochak H.. ( 2013;). Typing of Pneumocystis jirovecii isolates from Iranian immunosuppressed patients based on the internal transcribed spacer (ITS) region of the rRNA gene. . Med Mycol 51:, 843–850. [CrossRef][PubMed]
    [Google Scholar]
  59. Shipley T. W., Kling H. M., Morris A., Patil S., Kristoff J., Guyach S. E., Murphy J. E., Shao X., Sciurba F. C.. & other authors ( 2010;). Persistent pneumocystis colonization leads to the development of chronic obstructive pulmonary disease in a nonhuman primate model of AIDS. . J Infect Dis 202:, 302–312. [CrossRef][PubMed]
    [Google Scholar]
  60. Stringer S. L., Hudson K., Blase M. A., Walzer P. D., Cushion M. T., Stringer J. R.. ( 1989;). Sequence from ribosomal RNA of Pneumocystis carinii compared to those of four fungi suggests an ascomycetous affinity. . J Protozool 36:, 14S–16S. [CrossRef][PubMed]
    [Google Scholar]
  61. Takahashi T., Hosoya N., Endo T., Nakamura T., Sakashita H., Kimura K., Ohnishi K., Nakamura Y., Iwamoto A.. ( 2000;). Relationship between mutations in dihydropteroate synthase of Pneumocystis carinii f. sp. hominis isolates in Japan and resistance to sulfonamide therapy. . J Clin Microbiol 38:, 3161–3164.[PubMed]
    [Google Scholar]
  62. Totet A., Pautard J. C., Raccurt C., Roux P., Nevez G.. ( 2003;). Genotypes at the internal transcribed spacers of the nuclear rRNA operon of Pneumocystis jiroveci in nonimmunosuppressed infants without severe pneumonia. . J Clin Microbiol 41:, 1173–1180. [CrossRef][PubMed]
    [Google Scholar]
  63. Totet A., Duwat H., Magois E., Jounieaux V., Roux P., Raccurt C., Nevez G.. ( 2004;). Similar genotypes of Pneumocystis jirovecii in different forms of Pneumocystis infection. . Microbiology 150:, 1173–1178. [CrossRef][PubMed]
    [Google Scholar]
  64. Tsolaki A. G., Miller R. F., Underwood A. P., Banerji S., Wakefield A. E.. ( 1996;). Genetic diversity at the internal transcribed spacer regions of the rRNA operon among isolates of Pneumocystis carinii from AIDS patients with recurrent pneumonia. . J Infect Dis 174:, 141–156. [CrossRef][PubMed]
    [Google Scholar]
  65. Tsolaki A. G., Beckers P., Wakefield A. E.. ( 1998;). Pre-AIDS era isolates of Pneumocystis carinii f. sp. hominis: high genotype similarity with contemporary isolates. . J Clin Microbiol 36:, 90–93.[PubMed]
    [Google Scholar]
  66. Tsolaki A. G., Miller R. F., Wakefield A. E.. ( 1999;). Oropharyngeal samples for genotyping and monitoring response to treatment in AIDS patients with Pneumocystis carinii pneumonia. . J Med Microbiol 48:, 897–905. [CrossRef][PubMed]
    [Google Scholar]
  67. Tyagi A. K., Mirdha B. R., Guleria R., Mohan A., Luthra K., Singh U. B.. ( 2008;). Study of dihydropteroate synthase (DHPS) gene mutations among isolates of Pneumocystis jiroveci. . Indian J Med Res 128:, 734–739.[PubMed]
    [Google Scholar]
  68. Valerio A., Tronconi E., Mazza F., Fantoni G., Atzori C., Tartarone F., Duca P., Cargnel A.. ( 2007;). Genotyping of Pneumocystis jiroveci pneumonia in Italian AIDS patients. Clinical outcome is influenced by dihydropteroate synthase and not by internal transcribed spacer genotype. . J Acquir Immune Defic Syndr 45:, 521–528. [CrossRef][PubMed]
    [Google Scholar]
  69. van Hal S. J., Gilgado F., Doyle T., Barratt J., Stark D., Meyer W., Harkness J.. ( 2009;). Clinical significance and phylogenetic relationship of novel Australian Pneumocystis jirovecii genotypes. . J Clin Microbiol 47:, 1818–1823. [CrossRef][PubMed]
    [Google Scholar]
  70. Visconti E., Ortona E., Mencarini P., Margutti P., Marinaci S., Zolfo M., Siracusano A., Tamburrini E.. ( 2001;). Mutations in dihydropteroate synthase gene of Pneumocystis carinii in HIV patients with Pneumocystis carinii pneumonia. . Int J Antimicrob Agents 18:, 547–551. [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.076257-0
Loading
/content/journal/jmm/10.1099/jmm.0.076257-0
Loading

Data & Media loading...

Supplements

Supplementary Data 

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error